Entering addiction treatment means looking at the full picture of a patient’s current health. That includes any prescription medications they are currently taking. A prescription medication review clarifies why clinicians prescribed each medication and how it may affect treatment.
Many individuals seeking treatment for Substance Use Disorder (SUD) or Alcohol Use Disorder (AUD) are already taking prescription medications for mental health or medical conditions.
These medications are reviewed to understand potential interactions with alcohol or other substances. The review assesses withdrawal risks associated with the medications. It also determines whether continued monitoring is needed. This helps the clinical team plan care with a clearer understanding of the patient’s overall health.
Why Do Treatment Centers Review Medications?
Prescription Medications affect how a person feels physically and emotionally when they enter treatment, which is why reviewing them during the admissions process is important. The clinical team must know which medications are prescribed, their dosages, and how often patients take them. Current prescription medications could interact with other substances still in a patient’s system or with the medications that may be used during their treatment.
A full medication review identifies safety concerns related to withdrawal symptoms, misuse and dependence, or interactions with controlled substances that need to be monitored during treatment. This information helps the clinical team assess medications for anxiety, depression, ADHD, chronic pain, or other conditions. It shows which prescriptions require monitoring, continuation, or change by a medical provider.
Screening for Medications With Misuse or Dependence Risks
Certain prescription medications require closer review because they may carry risks related to misuse, addiction, physical dependence, or withdrawal. These can include benzodiazepines (benzos), prescription stimulants, and opioid medications. The FDA has issued safety warnings addressing these risks across all three medication classes.
Identifying these medications during admissions does not mean that a prescription has been used improperly. Some medications can cause physical dependence even when taken as prescribed. Physical dependence is not the same as addiction or a substance use disorder, although certain medications still carry misuse and addiction risks.
Identifying Potential Drug Interactions and Safety Concerns
Prescription medications can interact with alcohol, illicit drugs, or other medications in ways that create additional safety concerns. One important example is the combination of opioids with benzos, alcohol, or other central nervous system depressants. These combinations can cause extreme sedation and slow or impair breathing, which can become life-threatening.
A full prescription medication review allows the clinical team to identify these risks before treatment begins. Providers can consider current prescriptions alongside recent substance use and medications that may be used during treatment. When an interaction or other concern is identified, the medical team can determine whether closer monitoring, medication management, or another clinical approach may be appropriate.
Understanding Current Mental Health and Medical Needs
A patient’s prescription history can provide important context about existing mental health and medical needs. Medications for depression, anxiety, bipolar disorder, ADHD, chronic pain, sleep concerns, or other conditions may need to be considered alongside treatment for Substance Use Disorder (SUD) or Alcohol Use Disorder (AUD). The medication review is one part of a broader clinical assessment used to understand the patient as a whole.
This is especially important when substance use and mental health conditions occur together. SAMHSA recommends integrated care for co-occurring mental health and substance use disorders so both areas can be addressed rather than treating one in isolation. Reviewing current medications can support continuity of care, reduce the risk of overlooked medication concerns, and help create a treatment plan that is based on each patient’s clinical needs.
What Medications Are Reviewed During the Admissions Process?
During the review process, the clinical team gathers information about a patient’s current prescriptions, recent medications, and any other substances or medications they may be taking. This helps providers understand the patient’s health needs, identify potential safety concerns, and determine how medications should be managed throughout treatment.
Psychiatric Medications
Medications used to treat depression, anxiety, bipolar disorder, schizophrenia, and other mental health conditions are an important part of the admissions review. These may include antidepressants such as sertraline (Zoloft), fluoxetine (Prozac), or escitalopram (Lexapro); mood stabilizers such as lithium; and antipsychotic medications such as quetiapine (Seroquel) or risperidone (Risperdal). Reviewing these medications helps the clinical team understand existing mental health needs and determine a safe treatment plan.
Prescription Pain Medications
Prescription pain medications are reviewed because some can cause physical dependence, withdrawal symptoms, or potentially dangerous interactions with alcohol and other substances. These may include opioid medications such as oxycodone (OxyContin), hydrocodone, morphine, or tramadol. Information about dosage, frequency, and the reason for the prescription helps the clinical team anticipate withdrawal concerns and determine how to manage pain safely.
Sedative Medications
Sedative medications require careful review because they can cause physical dependence and may lead to serious withdrawal symptoms if stopped suddenly. Common benzodiazepines include alprazolam (Xanax), lorazepam (Ativan), clonazepam (Klonopin), and diazepam (Valium). Reviewing these medications before admission helps the clinical team assess withdrawal risk, possible drug interactions, and whether additional medical monitoring may be appropriate.
Medications for ADHD and Other Health Conditions
ADHD medications may include prescription stimulants such as amphetamine/dextroamphetamine (Adderall), methylphenidate (Ritalin or Concerta), and dextroamphetamine (Dexedrine). Because prescription stimulants can carry risks related to misuse, dependence, and addiction, they are reviewed carefully during the admissions process. Medications used for other ongoing health conditions are also important to disclose so the treatment team can understand the patient’s broader medical needs and coordinate care appropriately.
Does Taking Prescription Medication Affect Your Eligibility for Addiction Treatment?
Taking prescription medications does not automatically prevent you from entering treatment. The clinical team reviews your medications alongside your substance use, mental health, medical history, and current symptoms to determine whether the program can safely meet your needs. Some prescriptions simply need to be documented, while others may require additional evaluation or monitoring. Many people entering addiction treatment already take medications for depression, anxiety, ADHD, chronic pain, or other health conditions. Having a prescription does not mean you cannot receive treatment. The purpose of a medication review is to understand how your current medications fit into your care and what changes should be made to support safety and comfort.
Why Some Medications Require Additional Clinical Review
Certain medications require closer review because they can affect withdrawal, sedation, mental health symptoms, or interact with other substances. Opioids, benzodiazepines, prescription stimulants, and other controlled medications may require additional assessment based on how they are being used, the prescribed dosage, and the patient’s medical and substance use history. Benzodiazepines, for example, can cause physical dependence even when taken as prescribed and may produce serious withdrawal reactions if discontinued too quickly.
How Medication Review Helps Determine the Right Level of Care
A medication review gives the clinical team a clearer understanding of a patient’s current health needs before treatment begins. Certain medications may affect the amount of medical monitoring needed during the early stages of care. This information is considered alongside the patient’s substance use history, medical history, mental health concerns, and current symptoms. Together, these factors help providers assess the level of support and supervision needed.
For some patients, medical detoxification may be necessary before transitioning into residential or another level of addiction treatment. For others, treatment may begin without detox. A thorough medication review helps the clinical team make that determination as safely and appropriately as possible.
Depending on a patient’s withdrawal risk, medical needs, mental health symptoms, and overall stability, the clinical team may recommend different levels of care. ASAM describes addiction treatment as a continuum, with placement based on an individualized assessment of clinical needs.
- Medical Detoxification: Provides medical support and monitoring while alcohol, drugs, or certain medications leave the body. Detox may be recommended when withdrawal symptoms could be difficult or unsafe to manage without clinical supervision.
- Residential Treatment: Provides structured, 24-hour support in a live-in treatment setting. Residential care may be appropriate when a patient benefits from greater stability, supervision, and separation from environments that could interfere with early recovery.
- Partial Hospitalization Program (PHP): Provides a high level of structured treatment during the day while allowing patients to live near the facility. PHP can offer intensive therapy, clinical support, and medication management without requiring overnight residence.
- Intensive Outpatient Program (IOP): Provides structured therapy and support for several hours on multiple days each week while allowing patients to continue living in a supportive environment. IOP may be appropriate for patients who are medically stable but still need more support than standard outpatient care.
Why Prescription Medications Should Not Be Stopped Before Admission Without Medical Guidance
Stopping certain prescription medications abruptly can create intense withdrawal symptoms or other health risks. Benzodiazepines may require a gradual taper to reduce the risk of severe withdrawal reactions, while suddenly discontinuing opioid pain medications in a physically dependent patient can lead to significant withdrawal and uncontrolled pain. Medication changes should therefore be guided by a qualified medical provider rather than made solely in preparation for entering addiction treatment.
Common Withdrawal Symptoms From Alcohol, Drugs, and Prescription Medications
Withdrawal happens when the body has adapted to the presence of a substance and that substance is stopped or significantly reduced. Symptoms can range from uncomfortable to medically serious depending on the drug, how much and how often it was used, and for how long it was taken. Physical dependence can also develop with certain prescription medications even when they are taken exactly as prescribed, so experiencing withdrawal does not necessarily mean someone has a substance use disorder.
Withdrawal From Alcohol and Other Drugs
Alcohol withdrawal can occur when someone who has been drinking heavily or regularly stops drinking or significantly reduces their alcohol use.
Common symptoms include:
- Sweating
- Anxiety
- Restlessness
- Nausea
- Trouble Sleeping
- Rapid Heart Rate
In more severe cases, withdrawal from alcohol can lead to:
- Seizures
- Hallucinations
- Delirium Tremens (DT’s)
Because it can be difficult to predict how severe alcohol withdrawal will become based on symptoms alone, a clinical assessment is important when someone has a history of heavy or prolonged alcohol use. Depending on a person’s withdrawal history, current symptoms, medical needs, and other risk factors, medically monitored withdrawal management may be recommended before or as part of addiction treatment.
Withdrawal From Illicit Drugs
Different substances produce different patterns of withdrawal. Common examples include:
- Heroin and Other Opioids:
- Muscle Aches
- Sweating
- Restlessness
- Anxiety
- Nausea
- Vomiting
- Diarrhea
- Abdominal Cramping
- Runny Nose
- Difficulty Sleeping.
- Cocaine:
- Fatigue
- Depressed Mood
- Irritability
- Changes in Sleep
- Difficulty Concentrating
- Methamphetamine:
- Fatigue
- Depression
- Anxiety
- Irritability
- Sleep Disturbances
- Cravings
Withdrawal from stimulants such as cocaine and methamphetamine often has a significant emotional and psychological component, while opioid withdrawal commonly causes prominent physical symptoms. Symptoms may continue beyond the initial withdrawal period for some people.
Withdrawal From Prescription Medications
Prescription medications can also cause withdrawal or discontinuation symptoms, particularly when they are stopped suddenly after the body has become physically dependent on them.
- Prescription opioids such as oxycodone, hydrocodone, morphine, or fentanyl may cause restlessness, sweating, muscle and joint pain, anxiety, insomnia, nausea, vomiting, diarrhea, and abdominal cramps.
- Benzodiazepines such as Xanax (alprazolam), Ativan (lorazepam), Klonopin (clonazepam), or Valium (diazepam) can cause anxiety, insomnia, tremors, agitation, and other withdrawal symptoms. Severe withdrawal can include seizures, which is one reason these medications should not be stopped abruptly without medical guidance.
- Prescription stimulants such as Adderall or Ritalin can be associated with dependence and withdrawal concerns even when taken as prescribed.
- Antidepressants can cause what clinicians generally refer to as discontinuation symptoms rather than addiction-related withdrawal. Depending on the medication, abruptly stopping may lead to symptoms such as nausea, dizziness, anxiety, irritability, sleep problems, sweating, headache, or unusual sensory sensations.
Can Prescription Medication Be Continued During Addiction Treatment?
Many prescription medications can be continued during addiction treatment when they remain clinically appropriate. The clinical team reviews each medication individually, considering the condition being treated, dosage, potential interactions, substance use history, and overall health. The goal is to support continuity of necessary care while making sure medications can be managed safely within the treatment setting.
When Medication Changes May Be Recommended in Treatment
In some cases, a medical provider may recommend adjusting a medication, changing the dosage, or considering an alternative. Changes may be considered when a medication creates safety concerns, interacts with other substances or medications, is no longer effective, or carries risks that require closer attention during recovery. Any changes should be based on an individual clinical assessment rather than made automatically because a patient has entered addiction treatment.
The Role of Medication Management During Addiction Treatment
Medication management during addiction treatment is more than keeping track of prescriptions. Medical providers evaluate whether medications remain appropriate as a patient stabilizes and progresses through treatment. This can include monitoring effectiveness, side effects, withdrawal symptoms, potential drug interactions, and changes in physical or mental health. Medication may also be used as part of evidence-based treatment for certain substance use disorders. SAMHSA notes that medications combined with counseling and behavioral therapies can be an important part of treatment for some patients with SUD.
Depending on the diagnosis and individual treatment plan, medications used during addiction treatment may include:
- Medications for Alcohol Use Disorder (AUD): naltrexone, acamprosate, and disulfiram are FDA-approved options. Naltrexone can help reduce the urge to drink, while acamprosate can support continued abstinence.
- Medications for Opioid Use Disorder (OUD): buprenorphine, methadone, and naltrexone are FDA-approved treatments for OUD. These medications can help reduce illicit opioid use and support ongoing recovery.
- Medications for opioid withdrawal symptoms: lofexidine (Lucemyra) is a non-opioid medication approved by the FDA to help reduce symptoms of opioid withdrawal. It treats withdrawal symptoms rather than OUD itself.
- Non-controlled options for certain mental health symptoms: When clinically appropriate, providers may consider medications that do not carry the same misuse or dependence concerns as benzodiazepines or other controlled substances. Buspirone, for example, is a non-controlled medication indicated for anxiety disorders and does not have the same abuse or dependence profile as benzodiazepines.
The goal is not simply to remove controlled medications from a patient’s treatment plan. In fact, buprenorphine and methadone are controlled medications that have an established role in evidence-based treatment for OUD. Medication decisions should be based on diagnosis, safety, medical history, substance use history, and the patient’s response to treatment. For patients with co-occurring mental health conditions, medication management can also help ensure those needs continue to be addressed alongside addiction treatment.
What is Medication-Assisted Treatment?
Medication-Assisted Treatment (MAT) combines FDA-approved medications with counseling, behavioral therapies, and other recovery services to treat certain substance use disorders. MAT addresses both the physical and behavioral aspects of addiction. Depending on the diagnosis and individual treatment plan, medication may help reduce cravings, ease withdrawal symptoms, or support continued recovery.
MAT is most commonly used in the treatment of Opioid Use Disorder (OUD) and Alcohol Use Disorder (AUD). Medications for OUD include buprenorphine, methadone, and naltrexone. For AUD, medications such as naltrexone, acamprosate, and disulfiram may be considered. The medication selected, if any, depends on a patient’s diagnosis, medical history, current medications, substance use history, and other clinical needs.
Prescription Medication Review at Milton Recovery Centers
At Milton Recovery Centers, reviewing current medications is part of understanding the whole person before addiction treatment begins. During the admissions process, patients are encouraged to provide an accurate list of prescription medications, dosages, and any recent substance use so the clinical team can identify potential interactions, withdrawal concerns, and other medical or mental health needs. The purpose of a prescription medication review is not to judge the medications someone takes or automatically discontinue them. It helps providers determine how medications can be managed appropriately and whether additional medical support may be needed as treatment begins.
How Medication Review Helps Create a More Personalized Treatment Plan
A medication review gives the clinical team another piece of information needed to understand the whole person rather than focusing only on substance use. Current prescriptions, mental health needs, medical conditions, withdrawal risks, and previous treatment experiences can all influence the approach to care. Bringing these factors together helps providers develop a more individualized treatment plan that addresses both immediate safety and longer-term recovery needs.
Getting Started With Addiction Treatment in Florida
Reaching out for addiction treatment in the United States can begin with a confidential conversation about what the person is experiencing and the type of support they may need. Milton Recovery Centers in Florida and Ohio work with adults seeking treatment for substance use and co-occurring mental health conditions. During admissions, the team can review their treatment needs, current medications, health history, and insurance information to help determine whether Milton is an appropriate fit. Being open about the medications and substances that have been used gives providers the information they need to plan for a safer transition into treatment and the next stage of recovery.
